Market Tracker

08/29 6:01pm ET

TG Therapeutics Inc (NASDAQ:TGTX)

8.48
Data as of Aug 29
 -0.07 / -0.82%
Today’s Change
2.97
Today|||52-Week Range
11.56
+117.44%
Year-to-Date

Today’s Trading

Previous close8.55
Today’s open8.55
Day’s range8.34 - 8.58
Volume192,954
Average volume (3 months)472,158
Market cap$325.9M
Dividend yield--
Data as of 3:59pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)+41.30%
Earnings growth (this year)-58.33%
Earnings growth (next 5 years)--
Revenue growth (last year)+699.98%
P/E ratioNM
Price/Sales650.44
Price/Book7.32

Competitors

 Today’s
change
Today’s
% change
XNCRXencor Inc+0.40+3.89%
PTXPernix Therapeutics ...+0.26+3.08%
TTPHTetraphase Pharmaceu...+0.21+1.63%
ZIOPZIOPHARM Oncology In...+0.08+2.54%
Data as of 3:59pm ET, 08/29/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$152.4K
Annual profit (last year)-$20.5M
Net profit margin-13,438.82%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael S. Weiss
Chief Financial Officer, Treasurer &
Secretary
Sean A. Power
Corporate headquarters
New York, New York

Forecasts